Zhejiang Jolly Pharmaceutical Co.,LTD

¥12.52As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300181Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 4.08%
Div yield 5.59%
ROE 19.48%
Drug Manufacturers (General)
Beta (5Y) 0.23
PE TTM 14.10
TSR TTM (24.82%)
Mkt cap ¥8.711B
ROIC 17.27%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
15.91%
(30.03%)
Sell 9|0|11|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.17
0.18
0.18
21.51%
23.19%
24.91%
21.09%
Revenue¥M
433.3
442.9
466.6
465.0
5.81%
5.71%
9.58%
8.40%
Peers (US$1.306B)
Cap (US$)
PE
1.479B
—
1.197B
—
Capital
TTM
5Y
10Y
Leveragex
0.859
(0.450)
(0.408)
EBIT/Intx
1.684
0.104
0.102
Own earn%
(98.65)
103.91
91.07
Sh yield%
45.40
33.91
29.96
Owners
Insiders/Inst%
9.79
65.75
Short interest%
2.90
SBC / revenue%
3.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
27–34
$1 testx
—
Incr. ROIC%
6